Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.
HOUBEN, RM G J; LALLI, M; SUMNER, T; Hamilton, M; PEDRAZZOLI, D; Bonsu, F; Hippner, P; Pillay, Y; Kimerling, M; Ahmedov, S; Pretorius, C; WHITE, RG;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0608-4.
World TB Day 2016: an interview with leading experts in tuberculosis research.
Phillips, PP J; FLETCHER, HA; Abubakar, I; Lipman, MC I; McHugh, TD;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0591-9.
Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment.
Abubakar, I; Lipman, M; McHugh, TD; FLETCHER, H;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0599-1.
The impact of being homeless on the unsuccessful outcome of treatment of pulmonary TB in São Paulo State, Brazil.
Ranzani, OT; Carvalho, CR R; Waldman, EA; RODRIGUES, LC;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0584-8.
Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?.
Martin, LJ; Roper, MH; Grandjean, L; Gilman, RH; Coronel, J; Caviedes, L; Friedland, JS; MOORE, DA J;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0576-8.
Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
GUPTA-WRIGHT, A; PETERS, JA; Flach, C; LAWN, SD;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0603-9.
The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
Hermans, SM; GRANT, AD; Chihota, V; LEWIS, JJ; VYNNYCKY, E; CHURCHYARD, GJ; FIELDING, KL;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0589-3.
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.
PHELAN, J; COLL, F; McNerney, R; Ascher, DB; Pires, DE V; FURNHAM, N; Coeck, N; Hill-Cawthorne, GA; Nair, MB; Mallard, K; Ramsay, A; CAMPINO, S; HIBBERD, ML; Pain, A; Rigouts, L; CLARK, TG;
2016
BMC medicine, (2016).14 1 10.1186/s12916-016-0575-9.
A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Zak, DE; Penn-Nicholson, A; Scriba, TJ; Thompson, E; Suliman, S; Amon, LM; Mahomed, H; Erasmus, M; Whatney, W; Hussey, GD; Abrahams, D; Kafaar, F; Hawkridge, T; Verver, S; Hughes, EJ; Ota, M; SUTHERLAND, J; Howe, R; DOCKRELL, HM; Boom, WH; Thiel, B; Ottenhoff, TH M; Mayanja-Kizza, H; CRAMPIN, AC; Downing, K; ... ACS and GC6-74 cohort study groups,
2016
Lancet, (2016).387 10035 10.1016/S0140-6736(15)01316-1.
End TB strategy: the need to reduce risk inequalities.
Gomes, MG M; Barreto, ML; Glaziou, P; MEDLEY, GF; RODRIGUES, LC; Wallinga, J; Squire, SB;
2016
BMC infectious diseases, (2016).16 1 10.1186/s12879-016-1464-8.